Allogeneic bone marraw transplantation was performed in 3 patients of severe aplastic anemia, 3 patients of acute lymphocytic leukemia ans 1 patient of malignant lymphoma. One patient of aplastic anemia, 2 patients of acute leukemia and 1 patient of malignant lymphoma are alive for from 200 days to 3 years after transplantation. Two patients of aplastic anemia and 1 patient of acute leukemia caused graft rejection and failure of sustained engraftment, and ultimately died of fungal and cytomegalovirus infections. The clinical courses and the outcomes of these patients were presented referring to the recent progress of bone marrow transplantation.
allogeneic bone marraw transplanation
aplastic anemia
acute leukemia
malignant lymphoma